2,5-Hexanedione induced reduction in protein content and mRNA expression of neurofilament in rat cerebral cortex

Environmental Toxicology and Pharmacology

Volumn 20, Issue 1, 2005, Pages 92-98

  Zhang, Tian Liang ^a,b   Han, Xiao Ying ^a   Zhao, Xiu Lan ^a   Zhao, Li ^a   Zhang, Cui Li ^a   Yu, Li Hua ^a   Yu, Su Fang ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

^b Jinan Prefecture Center for Disease Control and Prevention   (China)

Author keywords

2,5 Hexanedione; Cerebral cortex; Immunoblotting; Neurofilament; RT PCR

Indexed keywords

ACETONYLACETONE; MESSENGER RNA; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; NEUROFILAMENT PROTEIN L; NEUROFILAMENT PROTEIN M; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; INTOXICATION; MALE; NEUROFILAMENT; NEUROPATHY; NEUROTOXICITY; NONHUMAN; OPTIC NERVE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

RATTUS NORVEGICUS;

EID: 18144395405     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2004.11.003     Document Type: Article

References (41)

1. M.M. Black, P. Keyser, and E. Sobel Interval between the synthesis and assembly of cytoskeletal proteins in cultured neurons J. Neurosci. 6 1986 1004 1012
2. M.J. Carden, V.M. Lee, and W.W. Schlaepfer 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins Neurochem. Pathol. 5 1986 25 35
3. R. Carney, C. Dardis, W.K. Cullen, V. Felipo, R. Anwyl, and M.J. Rowan Early spatial memory deficit induced by 2,5-hexanedione in the rat Toxicol. Lett. 10 2002 107 115
4. F.C. Chiu, L.A. Opanashuk, D.K. He, E.J. Lehning, and R.M. LoPachin gamma-diketone peripheral neuropathy. II. Neurofilament subunit content Toxicol. Appl. Pharmacol. 165 2000 141 147
5. D. Couri, and M. Milks Toxicity and metabolism of the neurotoxic hexacarbons n-hexane, 2-hexanone, and 2,5-hexanedione Annu. Rev. Pharmacol. Toxicol. 22 1982 145 166
6. T.C. De Rojas, and B.D. Goldstein Lack of evidence for the size principle of selective vulnerability of axons in toxic neuropathies. I. The effects of subcutaneous injections of 2,5-hexanedione on behavior and muscle spindle function Toxicol. Appl. Pharmacol. 104 1990 47 58
7. G.A. Elder, V.L. Friedrich Jr., A. Margita, and R.A. Lazzarini Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit J. Cell Biol. 146 1999 181 192
8. S.G. Gilbert, and J.P. Maurissen Assessment of the effects of acrylamide, methylmercury, and 2,5-hexanedione on motor functions in mice J. Toxicol. Environ. Health 10 1982 31 41
9. M. Hirata Reduced conduction function in central nervous system by 2,5-hexanedione Neurotoxicol. Teratol. 12 1990 623 626
10. P.N. Hoffman, J.W. Griffin, and D.L. Price Control of axonal caliber by neurofilament transport J. Cell Biol. 99 1984 705 714
11. J.P. Julien, and W.E. Mushynski Neurofilaments in health and disease Prog. Nucleic Acid Res. Mol. Biol. 61 1998 1 23
12. J.E. Karlsson, L.E. Rosengren, and K.G. Haglid Quantitative and qualitative alterations of neuronal and glial intermediate filaments in rat nervous system after exposure to 2,5-hexanedione J. Neurochem. 57 1991 1437 1444
13. D.M. Lapadula, E. Suwita, and M.B. Abou-Donia Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy Brain Res. 458 1988 123 131
14. M.K. Lee, and D.W. Cleveland Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease Curr. Opin. Cell Biol. 6 1994 34 40
15. E.J. Lehning, K.S. Dyer, B.S. Jortner, and R.M. LoPachin Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy Toxicol. Appl. Pharmacol. 135 1995 58 66
16. E.J. Lehning, B.S. Jortner, J.H. Fox, J.C. Arezzo, T. Kitano, and R.M. LoPachin gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling Toxicol. Appl. Pharmacol. 165 2000 127 140
17. R.M. LoPachin, D. He, M.L. Reid, and L.A. Opanashuk 2,5-Hexanedione- induced changes in the monomeric neurofilament protein content of rat spinal cord fractions Toxicol. Appl. Pharmacol. 198 2004 61 73
18. R.M. LoPachin, R.C. Jones, T.A. Patterson, W. Slikker Jr., and D.S. Barber Application of proteomics to the study of molecular mechanisms in neurotoxicology Neurotoxicollogy 24 2003 761 775
19. R.M. LoPachin, B.S. Jortner, M.L. Reid, and S. Das Gamma-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots Toxicol. Appl. Pharmacol. 193 2003 29 46
20. R.M. LoPachin, and E.J. Lehning The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper Neurotoxicology 18 1997 7 22
21. R.M. LoPachin, J.F. Ross, M.L. Reid, S. Das, S. Mansukhani, and E.J. Lehning Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione Neurotoxicology 23 2002 95 110
22. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
23. M.L. Mateus, A.P. dos Santos, and M.C. Batoreu Evidence of zinc protection against 2,5-hexanedione neurotoxicity: correlation of neurobehavioral testing with biomarkers of excretion Neurotoxicology 23 2002 747 754
24. S. Monaco, L. Autilio-Gambetti, R.J. Lasek, M.J. Katz, and P. Gambetti Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter Neuropathol. Exp. Neurol. 48 1989 23 32
25. S. Monaco, L. Autilio-Gambetti, D. Zabel, and P. Gambetti Giant axonal neuropathy: acceleration of neurofilament transport in optic axons Proc. Natl. Acad. Sci. U.S.A. 82 1985 920 924
26. G. Moretto, S. Monaco, M.G. Passarin, M.D. Benedetti, and N. Rizzuto Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro Arch. Toxicol. 65 1991 409 413
27. P.F. Moskowitz, and M.M. Oblinger Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain Brain Res. Mol. Brain Res. 30 1995 211 222
28. M. Nagano, H. Yamamoto, K. Harada, E. Miyamoto, and M. Futatsuka Comparative study of modification and degradation of neurofilament proteins in rats subchronically treated with allyl chloride, acrylamide, or 2,5-hexanedione Environ. Res. 63 1993 229 240
29. R.A. Nixon Dynamic behavior and organization of cytoskeletal proteins in neurons: reconciling old and new findings Bioessays 20 1998 798 807
30. L.A. Opanashuk, D.K. He, E.J. Lehning, and R.M. Lopachin γ-Diketone peripheral Neuropathy III. Neurofilament gene expression Neurotoxicology 22 2001 215 220
31. H.C. Pant Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain Biochem. J. 256 1988 665 668
32. M.E. Pereira, J.B. Rocha, and I. Izquierdo Atropine reverses antinociception induced by 2,5-hexanedione in rats Pharmacol. Toxicol. 77 1995 91 94
33. S.J. Pyle, V. Amarnath, D.G. Graham, and D.C. Anthony Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione exposure Cell Motil. Cytoskeleton 26 1993 133 143
34. P.S. Spencer, and H.H. Schaumburg Neurotoxic properties of certain aliphatic hexacarbons Proc. R. Soc. Med. 70 1977 37 38
35. P.S. Spencer, and H.H. Schaumburg Ultrastructural studies of the dying-back process. III. The evolution of experimental peripheral giant axonal degeneration J. Neuropathol. Exp. Neurol. 36 1977 276 299
36. P. Strange, A. Moller, O. Ladefoged, H.R. Lam, J.J. Larsen, and P. Arlien-Soborg Total number and mean cell volume of neocortical neurons in rats exposed to 2,5-hexanedione with and without acetone Neurotoxicol. Teratol. 13 1991 401 406
37. D.F. Watson, K.P. Fittro, P.N. Hoffman, and J.W. Griffin Phosphorylation-related immunoreactivity and the rate of transport of neurofilaments in chronic 2,5-hexanedione intoxication Brain Res. 539 1991 103 109
38. K. Xie, R.P. Gupta, and M.B. Abou-Donia Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride Neurochem. Res. 26 2001 235 243
39. J.T. Yabe, W.K. Chan, T.M. Chylinski, S. Lee, A.F. Pimenta, and T.B. Shea The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation, and maturation Cell Motil. Cytoskeleton 48 2001 61 83
40. Y. Yagi Effects of 2,5-hexanedione on rat spinal pyramidal tract Jpn. J. Ind. Health 36 1994 73 180
41. X.L. Zhao, Z.P. Zhu, T.L. Zhang, C.L. Zhang, L.H. Yu, and K.Q. Xie Tri-ortho-cresyl phosphate (TOCP) decreases the levels of cytoskeletal proteins in hen sciatic nerve Toxicol. Lett. 152 2004 139 147